Health-related quality of life and cost of ambulatory care in osteoporosis: how may such outcome measures be valuable information to health decision makers and payers?

被引:22
作者
Ethgen, O
Tellier, V
Sedrine, WB
De Maeseneer, J
Gosset, C
Reginster, JY
机构
[1] Univ Liege, Dept Epidemiol & Publ Hlth, CHU Sart Tilman, B-4020 Liege, Belgium
[2] WHO Collaborating Ctr, Public Hlth Aspects Osteoarticular Disorders, Liege, Belgium
[3] Univ Ghent, Dept Gen Practice & Primary Hlth Care, Ghent, Belgium
[4] Univ Liege, Bone & Cartilage Res Unit, Liege, Belgium
关键词
osteoporosis; health-related quality of life; cost; ambulatory care; health service research;
D O I
10.1016/S8756-3282(03)00089-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective was to quantify the outcome of osteoporosis (OP) in terms of health-related quality of life (HR-QOL) and cost of ambulatory care and to look at the association between these two outcomes variables. A cross-sectional health survey of 4800 Belgian individuals over the age of 45 years was used. Individuals having reported OP were retrieved and for each of them, at least two matched individuals for age, sex, residency location, and health insurance status were identified. All individuals were assessed with the SF-36. The two major health insurance providers furnished cost value for ambulatory care. HR-QOL and cost data were compared between the OP group and control group. beta-Coefficients from linear regression were calculated to give information oil the relative importance of the association between each SF-36 dimensions and cost of ambulatory care. Of 4796 individuals appropriately surveyed, 221 (4.8%) reported OP. The control group included 651 individuals. The OP group experienced impaired HR-QOL compared to their matched counterparts, all the difference in mean or median SF-36 scores being significant at the level of P < 0.001. Osteoporotic respondents averaged Euro816 in cost of ambulatory care whereas controls averaged Euro579 (P < 0.001). When looking at detailed comparisons between categories of cost, costs ill the OP group far exceeded those in the control group, all the differences being significant at the level of P < 0.001 except for home health nurse (P = 0.012). In the OP group, vitality dimensions played the most important role in the determination of cost (beta = -0.28, P < 0.001), followed by physical functioning (beta = -0.26, P < 0.01), general health, and social functioning (beta = -0.23, P < 0.01). This study evidences the burden of OP in terms of HR-QOL and cost of ambulatory care. Exploring the association between HR-QOL and cost show that mental dimension such as vitality can play an important role in the determination of cost. Conclusively, they should not be neglected in future management of OP. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:718 / 724
页数:7
相关论文
共 42 条
  • [1] Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations
    Aaronson, NK
    Muller, M
    Cohen, PDA
    Essink-Bot, ML
    Fekkes, M
    Sanderman, R
    Sprangers, MAG
    Velde, AT
    Verrips, E
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) : 1055 - 1068
  • [2] Altose MD, 2000, NEW ENGL J MED, V343, P1902
  • [3] [Anonymous], 1996, Quality of Life and Pharmacoeconomics in Clinical Trials
  • [4] A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis
    Burke, TA
    Zabinski, RA
    Pettitt, D
    Maniadakis, N
    Maurath, CJ
    Goldstein, JL
    [J]. PHARMACOECONOMICS, 2001, 19 (01) : 33 - 47
  • [5] COSTS AND HEALTH-EFFECTS OF OSTEOPOROTIC FRACTURES
    CHRISCHILLES, E
    SHIREMAN, T
    WALLACE, R
    [J]. BONE, 1994, 15 (04) : 377 - 386
  • [6] A MODEL OF LIFETIME OSTEOPOROSIS IMPACT
    CHRISCHILLES, EA
    BUTLER, CD
    DAVIS, CS
    WALLACE, RB
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (10) : 2026 - 2032
  • [7] QUALITY-OF-LIFE ISSUES IN WOMEN WITH VERTEBRAL FRACTURES DUE TO OSTEOPOROSIS
    COOK, DJ
    GUYATT, GH
    ADACHI, JD
    CLIFTON, J
    GRIFFITH, LE
    EPSTEIN, RS
    JUNIPER, EF
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (06): : 750 - 756
  • [8] Cook DJ, 1997, OSTEOPOROSIS INT, V7, P478
  • [9] Predictors of health care utilization in the chronically ill: a review of the literature
    deBoer, AGEM
    Wijker, W
    deHaes, HCJM
    [J]. HEALTH POLICY, 1997, 42 (02) : 101 - 115
  • [10] Eisenberg J M, 1992, Pharmacoeconomics, V1, P2, DOI 10.2165/00019053-199201010-00002